Oliver Symes Ollie Symes is our Research Support Officer. Ollie enjoys reading, discovering and writing about the latest MS research. Home Oliver Symes Add bookmark Blogs by Oliver Symes Read more blogs from our MS community Co-creating an activity package for people with progressive MS LEAP-MS was a lifestyle, exercise and activity package for people with progressive MS. We had a chat with Ann Jones about her experience co-designing and testing the programme from its earliest stages as a person with MS. Under the microscope: what is the potential of BTK inhibitors? Bruton’s tyrosine kinase (BTK) inhibitors are an emerging type of disease modifying therapy (DMT) for MS.
Co-creating an activity package for people with progressive MS LEAP-MS was a lifestyle, exercise and activity package for people with progressive MS. We had a chat with Ann Jones about her experience co-designing and testing the programme from its earliest stages as a person with MS.
Under the microscope: what is the potential of BTK inhibitors? Bruton’s tyrosine kinase (BTK) inhibitors are an emerging type of disease modifying therapy (DMT) for MS.
